In Re Medical Engineering Corporation

976 F.2d 746
CourtCourt of Appeals for the Federal Circuit
DecidedJune 12, 1992
Docket331
StatusUnpublished

This text of 976 F.2d 746 (In Re Medical Engineering Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Medical Engineering Corporation, 976 F.2d 746 (Fed. Cir. 1992).

Opinion

976 F.2d 746

NOTICE: Federal Circuit Local Rule 47.8(b) states that opinions and orders which are designated as not citable as precedent shall not be employed or cited as precedent. This does not preclude assertion of issues of claim preclusion, issue preclusion, judicial estoppel, law of the case or the like based on a decision of the Court rendered in a nonprecedential opinion or order.
In re MEDICAL ENGINEERING CORPORATION, Petitioner.

Misc. No. 331.

United States Court of Appeals, Federal Circuit.

June 12, 1992.

Before LOURIE, Circuit Judge, COWEN, Senior Circuit Judge, and RADER, Circuit Judge.

ON PETITION FOR WRIT OF MANDAMUS

RADER, Circuit Judge.

ORDER

Medical Engineering Corporation (MEC) petitions for a writ of mandamus to direct the United States District Court for the District of Minnesota to vacate its December 11, 1991 order staying proceedings pending arbitration and to conduct a jury trial regarding the arbitrability of certain issues. American Medical Systems, Inc. (AMS) opposes.

BACKGROUND

MEC sued AMS for infringement of certain claims of three of its patents directed to penile implants. AMS' "Dynaflex" penile prosthesis is the allegedly infringing product. AMS argued that sales of Dynaflex were not infringing because they were covered by licensing agreements between AMS and MEC.

AMS moved to stay proceedings pending arbitration and to compel arbitration. AMS argued that various agreements required that certain disputes raised in the present case be reviewed in arbitration proceedings. On December 11, 1991, the district court stayed proceedings pending arbitration. MEC moved for reconsideration on the ground that the district court failed to hold "an evidentiary jury trial on the sharply disputed issue of the parties' intent" to arbitrate such disputes. The district court denied reconsideration.

Settlement and Arbitration Agreements

In March of 1985, AMS, MEC and Dr. Said Hakky1 signed a settlement agreement (Hakky agreement) concerning the priority of conflicting claims arising in an interference involving an AMS patent and Dr. Hakky's patent application. In particular, section 15.1 concerned the scope of claims to be licensed therein and binding arbitration. Section 15.1 stated:

15.1. The parties agree to submit any dispute (a) concerning whether a particular product or process comes within the scope of a claim licensed hereunder, or (b) concerning the validity or enforceability of any such claim under the patent laws of the United States, to arbitration in accordance with the provisions of 35 U.S.C. § 294, except that any award in such arbitration proceedings shall be binding and nonappealable.

Later in March of 1985, AMS and MEC signed a settlement agreement (1985 agreement) concerning the priority of claims arising in another interference involving an AMS patent and an MEC patent application. Among other sections, section 17.1 concerned the scope of claims licensed therein and binding arbitration. Sections 17.1 provided:

17.1. The parties agree to submit any dispute (a) concerning whether a particular product or process comes within the scope of a claim licensed hereunder, or (b) concerning the validity or enforceability of any such claim under the patent laws of the United States, to arbitration in accordance with the provisions of 35 U.S.C. § 294. Any award in such arbitration proceedings shall be binding and nonappealable....

In March of 1986, AMS and MEC signed a binding arbitration agreement (March arbitration agreement) to arbitrate whether AMS's Hydroflex penile prosthesis infringed one or more claims of one of MEC's patents at issue is this case, i.e., U.S. Patent No. 4,353,360 ('360 patent). Sections 2.1, 17.1, 19.1, and 19.3 referred to binding arbitration. These sections provided:

2.1. The parties, and each of them, agree to submit their present dispute whether AMS's HYDROFLEX device infringes any claim of MEC's '360 PATENT to binding arbitration in accordance with the provisions of 35 U.S.C. § 294.

* * *

17.1. The parties agree to submit any dispute concerning whether a particular product or process comes within the scope of a claim licensed hereunder to arbitration in accordance with the provisions of 35 U.S.C. § 294. Any award in such arbitration proceedings shall be binding and nonappealable.

19.1. The parties agree to resolve any dispute concerning whether a particular product comes within the scope of a claim licensed hereunder through binding arbitration in accordance with Section 17 hereof.

19.3. If AMS wins the arbitration contemplated hereby, and MEC subsequently contends that a device manufactured, used, and/or sold by AMS, other than the HYDROFLEX device, comes within the scope of any '360 PATENT claim but is not subject to the grant of immunity set forth herein, MEC shall notify AMS of its contention and give reasons for such contention.

(b) If MEC notifies AMS, within such thirty (30) day period, that it disputes AMS's contention, the dispute shall be resolved by binding arbitration in accordance with Section 17 hereof....

In July of 1986, before the arbitration contemplated by the March arbitration agreement was completed, AMS and MEC signed a settlement agreement (July settlement agreement). Therein, it appears that MEC granted AMS a license under the '360 patent to make, use and sell the Hydroflex. Sections 4 and 5.5 related to the effect of the July settlement agreement on the March arbitration agreement. Sections 4 and 5.5 provided:

[4.] Any contention by MEC that changes in the HYDROFLEX device cause that device to fall outside the scope of the license granted hereunder and within the scope of one or more claims of the '360 PATENT shall be communicated to AMS. Such contention shall be resolved in accordance with the BINDING ARBITRATION AGREEMENT exactly as the present dispute was to have been resolved, with schedules and selection of an arbitrator(s) to be agreed by the parties in good faith. The intent of the parties is to leave the BINDING ARBITRATION AGREEMENT and its related agreements in place as the vehicle for resolving, by binding arbitration, any renewed dispute concerning the HYDROFLEX device or future changes thereto and the '360 PATENT.

5.5. This Agreement constitutes the complete, final and sole Agreement between AMS and MEC with respect to the resolution of the present dispute concerning the HYDROFLEX device and the '360 PATENT. This Agreement specifically supersedes the BINDING ARBITRATION AGREEMENT and the related ESCROW and NONDISCLOSURE agreements between the parties and all prior and contemporaneous discussions, understandings or verbal agreements between the parties as they affect the resolution of the present dispute. This Agreement shall have no effect on any other written Agreement between the parties other than those specifically named above....

DISCUSSION

Citing 9 U.S.C. § 4, MEC argues that the district court erred by not holding a jury trial when MEC alleged that the parties did not intend to submit this type of dispute to arbitration. Section 4 provides:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

At&T Technologies, Inc. v. Communications Workers
475 U.S. 643 (Supreme Court, 1986)
Gulfstream Aerospace Corp. v. Mayacamas Corp.
485 U.S. 271 (Supreme Court, 1988)
Twin City Monorail, Inc. v. Robbins & Myers, Inc.
728 F.2d 1069 (Eighth Circuit, 1984)
Matterhorn, Inc. v. Ncr Corporation
763 F.2d 866 (Seventh Circuit, 1985)
In Re Cordis Corporation
769 F.2d 733 (Federal Circuit, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
976 F.2d 746, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-medical-engineering-corporation-cafc-1992.